The transcribed pseudogene RPSAP52 enhances the oncofetal HMGA2-IGF2BP2-RAS axis through LIN28B-dependent and independent let-7 inhibition

转录的假基因RPSAP52通过LIN28B依赖性和非依赖性的let-7抑制作用增强癌胚HMGA2-IGF2BP2-RAS轴。

阅读:2
作者:Cristina Oliveira-Mateos ,Anaís Sánchez-Castillo ,Marta Soler ,Aida Obiols-Guardia ,David Piñeyro ,Raquel Boque-Sastre ,Maria E Calleja-Cervantes ,Manuel Castro de Moura ,Anna Martínez-Cardús ,Teresa Rubio ,Joffrey Pelletier ,Maria Martínez-Iniesta ,David Herrero-Martín ,Oscar M Tirado ,Antonio Gentilella ,Alberto Villanueva ,Manel Esteller ,Lourdes Farré ,Sonia Guil

Abstract

One largely unknown question in cell biology is the discrimination between inconsequential and functional transcriptional events with relevant regulatory functions. Here, we find that the oncofetal HMGA2 gene is aberrantly reexpressed in many tumor types together with its antisense transcribed pseudogene RPSAP52. RPSAP52 is abundantly present in the cytoplasm, where it interacts with the RNA binding protein IGF2BP2/IMP2, facilitating its binding to mRNA targets, promoting their translation by mediating their recruitment on polysomes and enhancing proliferative and self-renewal pathways. Notably, downregulation of RPSAP52 impairs the balance between the oncogene LIN28B and the tumor suppressor let-7 family of miRNAs, inhibits cellular proliferation and migration in vitro and slows down tumor growth in vivo. In addition, high levels of RPSAP52 in patient samples associate with a worse prognosis in sarcomas. Overall, we reveal the roles of a transcribed pseudogene that may display properties of an oncofetal master regulator in human cancers.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。